DelSiTech is happy to announce our participation in CRS LNP – RNA Therapeutics symposium, to be held virtually from April 6-7th 2022.

DelSiTech certainly looks forward to understand the cutting edge solutions for LNP-RNA therapeutics and to address how Silica Matrix may address widespread challenges in drug delivery of sensitive APIs. DelSiTech Silica Matrix has seen a significant rise in applications, owing to the highly versatile nature of the technology, with unprecedented release tuneability, while remaining simple and robust enabling efficient and timely development processes.

Are you interested in meeting us to discuss more? Reach out to us here to schedule a meeting.